I read, thanks. A profit sharing deal versus the same in revenue-based royalties for the first few years will quickly turn to the advantage of the profit sharing, sure, I agree. Maybe a more transparent bidding process would have been more beneficial for the stock price in the near term.
The R&D thing I didn't know about. That does sound much better.
Yes. Are you comparing a 2.74B market cap company to someone and their buddies tinkering in their basement?!?
That's why I was asking. I assume the 16 thumbs down (let's get to 100?) is angry and confused people who bought at the top who won't even stand a simple question.
But MNKD is 2.74B market cap... so as I told tlasalvia2004 below, isn't it large enough to do this on its own or wait a bit to see what the best offer is?
Ok, so a big problem I have with this argument, even if it's a typical percent, is that MNKD is right now worth 2.74B. Those hundreds of millions can be achieved with a secondary, right? If Afrezza is their flagship product, and it's under patent protection for many years, wouldn't it make sense to sacrifice immediate growth for a higher slice of the pie?
Is a 35 / 65 split typical for new products in the industry?
Learn to read, numbskull. I was asking a question. If you can't answer it, GTFO.
Nice, 6 down thumbs for asking a question... geniuses.
That seems very high just to have someone sell your product. Please tell me why I am wrong.
And the banks stole from the people.... and most of all, those banks' CEOs have stolen from the investors. It's a circle of thievery that doesn't quite add up.
They revised their guidance down for the next quarter, which isn't encouraging. Sellers will drive ARO's stock price down another .50 to $1.00 in the coming weeks. At 2.50-3.00 it might be worth a try.